Tag: data quality

From Protocol to CtQ: Mapping Objectives, Endpoints and Key Processes

Posted on By digi

From Protocol to CtQ: Mapping Objectives, Endpoints and Key Processes From Protocol to CtQ: Mapping Objectives, Endpoints and Key Processes The conduct of clinical trials demands a meticulous approach to ensure that outcomes are not only statistically valid but also clinically meaningful. This step-by-step tutorial provides a pragmatic guide for clinical operations, regulatory affairs, and…

Read More “From Protocol to CtQ: Mapping Objectives, Endpoints and Key Processes” »

Critical-to-Quality (CtQ) Factors

CtQ Factor Libraries for Common Study Types and Therapeutic Areas

Posted on By digi

CtQ Factor Libraries for Common Study Types and Therapeutic Areas In the realm of clinical trials, especially concerning melanoma clinical trials, the identification and management of Critical-to-Quality (CtQ) factors is essential for ensuring both integrity and compliance. This article serves as a step-by-step tutorial guide aimed at clinical operations, regulatory affairs, and medical affairs professionals…

Read More “CtQ Factor Libraries for Common Study Types and Therapeutic Areas” »

Critical-to-Quality (CtQ) Factors

RACT Best Practices for Sponsors, CROs and Site Networks

Posted on By digi

RACT Best Practices for Sponsors, CROs and Site Networks RACT Best Practices for Sponsors, CROs and Site Networks In the landscape of clinical trials, the Risk Assessment Categorization Tool (RACT) serves as a pivotal component for ensuring compliance and enhancing patient safety. As the industry shifts toward Risk-Based Monitoring (RBM) and remote oversight, it becomes…

Read More “RACT Best Practices for Sponsors, CROs and Site Networks” »

Risk Assessment Categorization Tool (RACT)

Identifying Critical-to-Quality (CtQ) Factors That Drive Trial Success

Posted on By digi

Identifying Critical-to-Quality (CtQ) Factors That Drive Trial Success In the complex landscape of clinical trials, understanding the Critical-to-Quality (CtQ) factors is essential for ensuring the success of any trial. These factors play a pivotal role in bridging the gap between regulatory compliance and operational efficiency while enhancing data quality and patient safety. With an increasing…

Read More “Identifying Critical-to-Quality (CtQ) Factors That Drive Trial Success” »

Critical-to-Quality (CtQ) Factors

RACT for Decentralized and Hybrid Trial Designs

Posted on By digi

RACT for Decentralized and Hybrid Trial Designs RACT for Decentralized and Hybrid Trial Designs The clinical research landscape is evolving, especially with the rapid adoption of decentralized and hybrid trial designs. The introduction of the Risk Assessment Categorization Tool (RACT) provides a structured method for evaluating risks associated with clinical trials. In this comprehensive guide,…

Read More “RACT for Decentralized and Hybrid Trial Designs” »

Risk Assessment Categorization Tool (RACT)

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues

Posted on By digi

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues Inspection Case Studies: When Weak RACT Drove Serious Quality Issues In the rapidly evolving landscape of clinical trials, adhering to regulatory requirements and standards of quality becomes paramount. The advent of risk-based monitoring (RBM) and remote oversight has introduced new methodologies and tools, such as…

Read More “Inspection Case Studies: When Weak RACT Drove Serious Quality Issues” »

Risk Assessment Categorization Tool (RACT)

Linking RACT to CtQ Factors, QTLs and Vendor Oversight

Posted on By digi

Linking RACT to CtQ Factors, QTLs and Vendor Oversight In the evolving landscape of clinical trials, optimizing oversight mechanisms is imperative for ensuring compliance and data integrity. This step-by-step guide focuses on the Risk Assessment Categorization Tool (RACT), its correlation with Critical to Quality (CtQ) factors, Quality Tolerance Limits (QTLs), and the significance of vendor…

Read More “Linking RACT to CtQ Factors, QTLs and Vendor Oversight” »

Risk Assessment Categorization Tool (RACT)

Refreshing RACT Throughout the Study Lifecycle: When and How

Posted on By digi

Refreshing RACT Throughout the Study Lifecycle: When and How The Risk Assessment Categorization Tool (RACT) plays a crucial role in enhancing clinical trial oversight through effective risk-based monitoring (RBM). Addressing the need for a structured approach to risk assessments, RACT is an essential tool for clinical operations, regulatory affairs, and medical affairs professionals engaged in…

Read More “Refreshing RACT Throughout the Study Lifecycle: When and How” »

Risk Assessment Categorization Tool (RACT)

Regulatory Expectations for RACT Documentation in RBM Submissions

Posted on By digi

Regulatory Expectations for RACT Documentation in RBM Submissions Regulatory Expectations for RACT Documentation in RBM Submissions In the rapidly evolving landscape of clinical trials, effective monitoring strategies are pivotal for ensuring data integrity and patient safety. The Risk-Based Monitoring (RBM) approach, particularly in conjunction with the Risk Assessment Categorization Tool (RACT), has emerged as a…

Read More “Regulatory Expectations for RACT Documentation in RBM Submissions” »

Risk Assessment Categorization Tool (RACT)

Digital RACT Tools: Configuration, Dashboards and Governance

Posted on By digi

Digital RACT Tools: Configuration, Dashboards and Governance In the evolving landscape of clinical research management, the utilization of Digital Risk Assessment Categorization Tools (RACT) is becoming increasingly critical. This article provides a comprehensive step-by-step guide focused on configuring, managing dashboards, and establishing governance around RACT tools. Professional roles such as clinical operations, regulatory affairs, and…

Read More “Digital RACT Tools: Configuration, Dashboards and Governance” »

Risk Assessment Categorization Tool (RACT)